The role of Fc-FcγR interactions in IgG-mediated microbial neutralization

被引:128
作者
Bournazos, Stylianos [1 ]
DiLillo, David J. [1 ]
Ravetch, Jeffrey V. [1 ]
机构
[1] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA
关键词
RECEPTOR ENGAGEMENT DRIVES; IN-VIVO; MONOCLONAL-ANTIBODY; HUMANIZED MICE; CAPSULAR POLYSACCHARIDE; CRYPTOCOCCUS-NEOFORMANS; UNIVERSAL VACCINE; EFFECTOR FUNCTION; LIPID RAFTS; MOUSE MODEL;
D O I
10.1084/jem.20151267
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibodies are bifunctional molecules, containing a variable Fab domain that mediates binding specificity and a constant Fc domain that bridges antibody-coated targets with Fc gamma R-expressing cells that mediate effector functions. Although traditional mechanisms of antibody-mediated neutralization of microbes have been largely thought to result from Fab-antigen interactions, recent studies suggest that recruitment of Fc gamma R-expressing effector cells by antibodies is a major in vivo mechanism of antibody-mediated protection from infection. In this article, we review Fc gamma R biology, compare mammalian Fc gamma R families, and summarize recent evidence demonstrating the crucial role that Fc-Fc gamma R interactions play during in vivo protection from infection.
引用
收藏
页码:1361 / 1369
页数:9
相关论文
共 72 条
[31]   HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice [J].
Horwitz, Joshua A. ;
Halper-Stromberg, Ariel ;
Mouquet, Hugo ;
Gitlin, Alexander D. ;
Tretiakova, Anna ;
Eisenreich, Thomas R. ;
Malbec, Marine ;
Gravemann, Sophia ;
Billerbeck, Eva ;
Dorner, Marcus ;
Buening, Hildegard ;
Schwartz, Olivier ;
Knops, Elena ;
Kaiser, Rolf ;
Seaman, Michael S. ;
Wilson, James M. ;
Rice, Charles M. ;
Ploss, Alexander ;
Bjorkman, Pamela J. ;
Klein, Florian ;
Nussenzweig, Michel C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (41) :16538-16543
[32]   Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections [J].
Huber, VC ;
Lynch, JM ;
Bucher, DJ ;
Le, J ;
Metzger, DW .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7381-7388
[33]   Antibodies in HIV-1 Vaccine Development and Therapy [J].
Klein, Florian ;
Mouquet, Hugo ;
Dosenovic, Pia ;
Scheid, Johannes F. ;
Scharf, Louise ;
Nussenzweig, Michel C. .
SCIENCE, 2013, 341 (6151) :1199-1204
[34]   HIV therapy by a combination of broadly neutralizing antibodies in humanized mice [J].
Klein, Florian ;
Halper-Stromberg, Ariel ;
Horwitz, Joshua A. ;
Gruell, Henning ;
Scheid, Johannes F. ;
Bournazos, Stylianos ;
Mouquet, Hugo ;
Spatz, Linda A. ;
Diskin, Ron ;
Abadir, Alexander ;
Zang, Trinity ;
Dorner, Marcus ;
Billerbeck, Eva ;
Labitt, Rachael N. ;
Gaebler, Christian ;
Marcovecchio, Paola M. ;
Incesu, Reha-Baris ;
Eisenreich, Thomas R. ;
Bieniasz, Paul D. ;
Seaman, Michael S. ;
Bjorkman, Pamela J. ;
Ravetch, Jeffrey V. ;
Ploss, Alexander ;
Nussenzweig, Michel C. .
NATURE, 2012, 492 (7427) :118-+
[35]   Few and Far Between: How HIV May Be Evading Antibody Avidity [J].
Klein, Joshua S. ;
Bjorkman, Pamela J. .
PLOS PATHOGENS, 2010, 6 (05) :1-6
[36]   Mechanism of neutralization of influenza virus infectivity by antibodies [J].
Knossow, M ;
Gaudier, M ;
Douglas, A ;
Barrère, B ;
Bizebard, T ;
Barbey, C ;
Gigant, B ;
Skehelt, JJ .
VIROLOGY, 2002, 302 (02) :294-298
[37]   Evolutionary and immunological implications of contemporary HIV-1 variation [J].
Korber, B ;
Gaschen, B ;
Yusim, K ;
Thakallapally, R ;
Kesmir, C ;
Detours, V .
BRITISH MEDICAL BULLETIN, 2001, 58 :19-42
[38]   Broadly neutralizing antibodies against influenza viruses [J].
Laursen, Nick S. ;
Wilson, Ian A. .
ANTIVIRAL RESEARCH, 2013, 98 (03) :476-483
[39]   Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination [J].
Lee, Yu-Na ;
Lee, Young-Tae ;
Kim, Min-Chul ;
Hwang, Hye Suk ;
Lee, Jong Seok ;
Kim, Ki-Hye ;
Kang, Sang-Moo .
IMMUNOLOGY, 2014, 143 (02) :300-309
[40]   Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies [J].
Li, Fubin ;
Ravetch, Jeffrey V. .
SCIENCE, 2011, 333 (6045) :1030-1034